Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Investigator-Initiated Trial (IIT) of PD-L1-Targeted Radionuclide Probes

NCT07848243 is registered in ClinicalTrials.gov with Peking University Cancer Hospital & Institute as lead sponsor.

NCT NCT07848243
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07848243 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Investigator-Initiated Trial (IIT) of PD-L1-Targeted Radionuclide Probes
Lead sponsor
Peking University Cancer Hospital & Institute
Phase
Phase 2
Overall status
Recruiting
Start date
February 1, 2026
Completion date
December 31, 2027
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, cervical squamous cell cancer, gastrointestinal cancers, lung cancer (nsclc), melanoma (skin cancer)